GHRH: Cognition in Aging and MCI.
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2016
At a glance
- Drugs Tesamorelin (Primary)
- Indications Mild cognitive impairment
- Focus Therapeutic Use
- Acronyms SMART
- 21 Dec 2013 NCT reports actual patient number as 151.
- 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.
- 19 Jul 2011 Results of this trial were presented at the Alzheimer's Association International Conference in July 2011, according to a Theratechnologies media release.